tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Edward Nash, 180 are a BUY (90%), 18 are a HOLD (9%), 2 are a SELL (1%).
Analyst Edward Nash, currently employed at CANACCORD, carries an average stock price target met ratio of 48.88% that have a potential upside of 43.84% achieved within 300 days.
Edward Nash’s has documented 390 price targets and ratings displayed on 42 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VTYX, Ventyx Biosciences at 08-Jan-2026.
Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 6/6/2017. The price target of $1398.96 was fulfilled within 1 day with a profit of $127.57 (10.03%) receiving and performance score of 100.34.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 13-Nov-2018
$3
$2.89 (2627.27%)
$10
7 years 1 months 29 days ago
(13-Nov-2018)
0/5 (0%)
$1.07 (55.44%)
Buy
Since 06-Mar-2017
$3
$2.89 (2627.27%)
$22
7 years 1 months 30 days ago
(12-Nov-2018)
0/3 (0%)
$1 (50.00%)
Hold
Since 12-Nov-2018
$3
$2.89 (2627.27%)
$19
7 years 1 months 30 days ago
(12-Nov-2018)
0/5 (0%)
$1 (50.00%)
Hold
Since 06-Nov-2018
$8
7 years 2 months 2 days ago
(09-Nov-2018)
1/6 (16.67%)
$4.75 (146.15%)
40
Hold
7 years 2 months 2 days ago
(09-Nov-2018)
1/4 (25%)
$8.57 (47.07%)
31
Which stock is Edward Nash is most bullish on?
Which stock is Edward Nash is most reserved on?
What Year was the first public recommendation made by Edward Nash?
